Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Danièle Pastier"'
Autor:
Sonia Dugué-Pujol, Xavier Rousset, Danielle Château, Danièle Pastier, Christophe Klein, Jeannine Demeurie, Charlotte Cywiner-Golenzer, Michèle Chabert, Pierre Verroust, Jean Chambaz, François-Patrick Châtelet, Athina-Despina Kalopissis
Publikováno v:
Journal of Lipid Research, Vol 48, Iss 10, Pp 2151-2161 (2007)
We investigated in vivo catabolism of apolipoprotein A-II (apo A-II), a major determinant of plasma HDL levels. Like apoA-I, murine apoA-II (mapoA-II) and human apoA-II (hapoA-II) were reabsorbed in the first segment of kidney proximal tubules of con
Externí odkaz:
https://doaj.org/article/07e229707e2444f58477b2dbc9d2309b
Autor:
Sonia Dugué-Pujol, Xavier Rousset, Danièle Pastier, Nhuan Tran Quang, Virginie Pautre, Jean Chambaz, Michèle Chabert, Athina-Despina Kalopissis
Publikováno v:
Journal of Lipid Research, Vol 47, Iss 12, Pp 2631-2639 (2006)
Postprandial hypertriglyceridemia and low plasma HDL levels, which are principal features of the metabolic syndrome, are displayed by transgenic mice expressing human apolipoprotein A-II (hapoA-II). In these mice, hypertriglyceridemia results from th
Externí odkaz:
https://doaj.org/article/b47f65de697d4215a43a867f5e446e9a
Autor:
Elisabeth Boisfer, Dominique Stengel, Danièle Pastier, P. Michel Laplaud, Nicole Dousset, Ewa Ninio, Athina-Despina Kalopissis
Publikováno v:
Journal of Lipid Research, Vol 43, Iss 5, Pp 732-741 (2002)
Transgenic mice overexpressing human apolipoprotein A-II (huapoA-II) display high VLDL and low HDL levels. To evaluate the antioxidant potential of huapoA-II enriched HDL, we measured the activities of paraoxonase (PON) and platelet-activating factor
Externí odkaz:
https://doaj.org/article/2c82ada1167b4ebfa3ff52767ce2b1e3
Autor:
Xavier Rousset, A.-D. Kalopissis, Danièle Pastier, Jeannine Demeurie, Jean Chambaz, Charlotte Cywiner-Golenzer, Christophe Klein, Danielle Château, Sonia Dugué-Pujol, François-Patrick Châtelet, Michèle Chabert, Pierre J. Verroust
Publikováno v:
Journal of Lipid Research, Vol 48, Iss 10, Pp 2151-2161 (2007)
We investigated in vivo catabolism of apolipoprotein A-II (apo A-II), a major determinant of plasma HDL levels. Like apoA-I, murine apoA-II (mapoA-II) and human apoA-II (hapoA-II) were reabsorbed in the first segment of kidney proximal tubules of con
Autor:
A.-D. Kalopissis, Michèle Chabert, Virginie Pautre, Sonia Dugué-Pujol, Nhuan Tran Quang, Xavier Rousset, Jean Chambaz, Danièle Pastier
Publikováno v:
Journal of Lipid Research, Vol 47, Iss 12, Pp 2631-2639 (2006)
Postprandial hypertriglyceridemia and low plasma HDL levels, which are principal features of the metabolic syndrome, are displayed by transgenic mice expressing human apolipoprotein A-II (hapoA-II). In these mice, hypertriglyceridemia results from th
Publikováno v:
Current Opinion in Lipidology. 14:165-172
Apolipoprotein A-II, the second major HDL apolipoprotein, was often considered of minor importance relatively to apolipoprotein A-I and its role was controversial. This picture is now rapidly changing, due to novel polymorphisms and mutations, to the
Autor:
Athina-Despina Kalopissis, V. Atger, Nicole Moatti, Jean-Louis Paul, Anne Cogny, Antonino Nicoletti, Jean Chambaz, Natalie Fournier, Danièle Pastier, Dominique Goudouneche
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 22:638-643
Overexpression of human apolipoprotein A-II (hapo A-II) in transgenic mice (hAIItg mice) induced marked hypertriglyceridemia and low levels of plasma high density lipoprotein (HDL) with a high hapo A-II content. We sought to determine whether cholest
Autor:
Chapman Mj, Tran Nq, Laplaud Pm, Atger, A.-D. Kalopissis, van Tol A, Dugué S, Jean Chambaz, Danièle Pastier, E. Boisfer
Publikováno v:
Biochemistry, 40, 12243-12253. American Chemical Society
Overexpression of human apolipoprotein A-II (apo A-II) in mice induced postprandial hypertriglyceridemia and marked reduction in plasma HDL concentration and particle size [Boisfer et al. (1999) J. Biol. Chem. 274, 11564-11572]. We presently compared
Publikováno v:
Journal of Biological Chemistry. 274:1216-1225
The activity of the human apoA-II promoter is controlled by a synergistic interaction of the distal enhancer and the proximal promoter. An important role in apoA-II promoter activity is exerted by a transcription factor, designated CIIIB1, which bind
Autor:
Philippe Cardot, Esther Fourniat, Agnès Ribeiro, Danièle Pastier, Jean Chambaz, Jean-Marc Lacorte
Publikováno v:
ResearcherID
We have previously shown that human apolipoprotein A-II (apoA-II) transcription is controlled by a complex set of regulatory elements. In this study, we demonstrate that the distal region of the apoA-II promoter (-911/-614) acts as an enhancer and re